Investing in Syndax Pharmaceuticals (NASDAQ:SNDX) Five Years Ago Would Have Delivered You a 53% Gain

Yahoo FinanceJan 10 22:16

Scotiabank Maintains Syndax Pharmaceuticals(SNDX.US) With Hold Rating, Cuts Target Price to $16

Futu NewsJan 8 23:31 · Ratings

Syndax Pharmaceuticals Is Maintained at Sector Perform by Scotiabank

Dow JonesJan 8 21:58 · Ratings

Syndax Pharmaceuticals Analyst Ratings

BenzingaJan 8 21:47 · Ratings

Express News | Syndax Pharmaceuticals Inc : Scotiabank Cuts Target Price to $16 From $18

BreakingsJan 8 19:53

Syndax Announces Presentation at 43rd Annual J.P. Morgan Healthcare Conference

PR NewswireJan 7 20:00